http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015176082-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47ec774ecbd5553cb613cc6b742c080d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ccd9707cab3cf58d4b225a571d203a6 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6809 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6844 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate | 2015-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c639b24bd9932675be34a80f9c401350 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91862ae7e4a187be9f23a22fbd631eea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c8b7c7449d0a58245b3499c1fcd9737 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3387c4f96b1f360513865f4d8a3ebbc |
publicationDate | 2015-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2015176082-A1 |
titleOfInvention | Plasma micrornas for the detection of early colorectal cancer |
abstract | The present invention relates in general to the field of colorectal cancer detection, and more particularly, to plasma microRNAs for the detection of early colorectal cancer. Specifically, the present invention includes methods, kits and biomarkers for diagnosing or detecting colorectal neoplasia in a human subject comprising the steps of: A method for diagnosing or detecting colorectal neoplasia in a human subject comprising the steps of: obtaining one or more biological samples from the subject suspected of suffering from colorectal neoplasia; measuring an overall expression pattern or level of one or more microRNAs obtained from the one or more biological samples of the subject; and comparing the overall expression pattern of the one or more microRNAs from the biological sample of the subject suspected of suffering from colorectal neoplasia with the overall expression pattern of the one or more microRNAs from a biological sample of a normal subject, wherein the normal subject is a healthy subject not suffering from colorectal neoplasia, wherein overexpression of a combination of miR19a and miR19b, or miR19a and miR19b and miR15b is indicative of colorectal cancer. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106950370-A |
priorityDate | 2011-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 159.